These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6689404)

  • 1. Tumor penetration of AMSA in man.
    Guo ZG; Savaraj N; Feun LG; Lu K; Stewart DJ; Luna M; Benjamin RS; Loo TL
    Cancer Invest; 1983; 1(6):475-8. PubMed ID: 6689404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human tissue distribution of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (NSC 141549, AMSA).
    Stewart DJ; Zhengang G; Lu K; Savaraj N; Feun LG; Luna M; Benjamin RS; Keating MJ; Loo TL
    Cancer Chemother Pharmacol; 1984; 12(2):116-9. PubMed ID: 6583026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrathecally administered m-AMSA in the rhesus monkey.
    Gormley P; Riccardi R; O'Neill D; Poplack D
    Cancer Drug Deliv; 1984; 1(2):101-7. PubMed ID: 6549572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II evaluation of m-AMSA (4'-(9-acridinylamino)-methanesulfon-m-anisidide) in patients with adenocarcinoma of the pancreas.
    Sternberg CN; Magill GB; Sordillo PP; Cheng E; Currie VE
    Am J Clin Oncol; 1983 Aug; 6(4):459-62. PubMed ID: 6688151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I evaluation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) by a weekly iv dose schedule.
    Woodcock TM; Schneider RJ; Young CW
    Cancer Treat Rep; 1980 Jan; 64(1):53-5. PubMed ID: 6892893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase II evaluation of m-AMSA, 4'-(9-acridinylamino) methanesulfon-m-anisidide, in patients with breast cancer.
    Currie VE; Howard J; Wittes R
    Cancer Clin Trials; 1981; 4(3):249-51. PubMed ID: 6895189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of viral growth by the antitumor drug 4'-(9-acridinylamino) methanesulfon-m-anisidide (m-AMSA).
    Drake S; Furlong NB; Nelson JA
    Biochem Pharmacol; 1983 Sep; 32(17):2615-8. PubMed ID: 6688528
    [No Abstract]   [Full Text] [Related]  

  • 8. 4'-(9-Acridinylamino) methanesulfon-m-anisidide (AMSA): a new drug effective in the treatment of adult acute leukemia.
    Legha SS; Keating MJ; Zander AR; McCredie KB; Bodey GP; Freireich EJ
    Ann Intern Med; 1980 Jul; 93(1):17-21. PubMed ID: 6930826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicity of 4'-(9-acridinylamino)methanesulfon-m-anisidide in exponential- and plateau-phase Chinese hamster cell cultures.
    Wilson WR; Giesbrecht JL; Hill RP; Whitmore GF
    Cancer Res; 1981 Jul; 41(7):2809-16. PubMed ID: 6894713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of 4'-(9-acridinylamino)methanesulfon-m-anisidide by rat liver microsomes.
    Shoemaker DD; Cysyk RL; Gormley PE; DeSouza JJ; Malspeis L
    Cancer Res; 1984 May; 44(5):1939-45. PubMed ID: 6546898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study of 4'-(9-acridinylamino) methanesulfon-m- anisidide (AMSA) in metastatic melanoma.
    Legha SS; Hall SW; Powell KC; Burgess MA; Benjamin RS; Gutterman JU; Bodey GP
    Cancer Clin Trials; 1980; 3(2):111-4. PubMed ID: 6893573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I-II study of m-AMSA administered as a continuous infusion.
    Micetich KC; Zwelling LA; Gormley P; Young RC
    Cancer Treat Rep; 1982 Oct; 66(10):1813-7. PubMed ID: 6897013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein-associated deoxyribonucleic acid strand breaks in L1210 cells treated with the deoxyribonucleic acid intercalating agents 4'-(9-acridinylamino) methanesulfon-m-anisidide and adriamycin.
    Zwelling LA; Michaels S; Erickson LC; Ungerleider RS; Nichols M; Kohn KW
    Biochemistry; 1981 Nov; 20(23):6553-63. PubMed ID: 6895473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II evaluation of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (m-AMSA) in patients with gastric adenocarcinoma.
    Sordillo PP; Magill GB; Gralla RJ; Kelsen DP
    Am J Clin Oncol; 1982 Jun; 5(3):273-5. PubMed ID: 6896259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in patients with metastatic hypernephroma.
    Schneider RJ; Woodcock TM; Yagoda A
    Cancer Treat Rep; 1980 Jan; 64(1):183-5. PubMed ID: 6892892
    [No Abstract]   [Full Text] [Related]  

  • 16. Phase II clinical evaluation of intravenous 4'-(9-acridinylamino)methanesulfon-m-anisidide in colorectal cancer.
    Valdivieso M; Stroehlein JR; Bedikian AY; Karlin DA; Legha SS; Bennetts RW; Bodey GP
    Am J Clin Oncol; 1983 Feb; 6(1):39-44. PubMed ID: 6687657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of 4'-(9-acridinylamino)methanesulfon-m-anisidide against Chinese hamster cells in multicellular spheroids.
    Wilson WR; Whitmore GF; Hill RP
    Cancer Res; 1981 Jul; 41(7):2817-22. PubMed ID: 7018670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cooperative sequestration of m-AMSA in L1210 cells.
    Zwelling LA; Kerrigan D; Michaels S; Kohn KW
    Biochem Pharmacol; 1982 Oct; 31(20):3269-77. PubMed ID: 6897359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II. Evaluation of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (AMSA) in patients with advanced sarcoma.
    Sordillo PP; Magill GB; Gralla RJ; Golbey RB
    Cancer Treat Rep; 1980; 64(10-11):1129-30. PubMed ID: 6893950
    [No Abstract]   [Full Text] [Related]  

  • 20. Biliary excretion of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in rats: effects of pretreatment with diethyl maleate, phenobarbital, and metyrapone.
    Shoemaker DD; Gormley PE; Cysyk RL
    Drug Metab Dispos; 1980; 8(6):467-8. PubMed ID: 6109618
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.